By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rubicon Genomics today said that Velesco Pharmaceutical Services will manufacture its Transplex kits that it will supply for use with Agendia's breast cancer diagnostics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.